SCHEMBL21158562

SCHEMBL21158562

CCCCOC(=O)c1cccc(-c2ncccc2C)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.54
LMNA P02545 2/20 0.49
HPGD P15428 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C19 P33261 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
NPC1 O15118 1/20 0.48
CYP2C9 P11712 1/20 0.48
RAB9A P51151 1/20 0.48
ESR1 P03372 4/20 0.48
ROCK2 O75116 2/20 0.47
MAPT P10636 2/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
KMT2A Q03164 1/20 0.45
CNR2 P34972 1/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
NR1H2 P55055 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16237821 0.89 TP53 (0.49) HPGDSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL27828485 0.81 CYP1A2 (0.47) L3MBTL1LMNAHPGDCYP1A2CYP2C19
SCHEMBL15151310 0.80 CYP2A6 (0.45) L3MBTL1HPGDALDH1A1
SCHEMBL13996229 0.79 L3MBTL1 (0.56) L3MBTL1LMNAHPGDCYP1A2CYP2C19
SCHEMBL725346 0.78 TRPV1 (0.46) L3MBTL1HPGDALDH1A1
SCHEMBL111861 0.77 L3MBTL1 (0.64) L3MBTL1LMNAHPGDCYP1A2CYP2C19
SCHEMBL5030948 0.77 CYP1A2 (0.60) L3MBTL1LMNAHPGDCYP1A2CYP2C19
SCHEMBL27806372 0.77 ALDH1A1 (0.50) L3MBTL1HPGDALDH1A1TSHR
SCHEMBL16237057 0.77 SYK (0.48) HPGDSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL12267358 0.76 CYP2A6 (0.50) ROCK2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2555755-B2 PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIODIN-2-YL)BENZOIC ACID AND ADMINISTRATION THEREOF VERTEX PHARMA (US) 2019-07-10 EP disclosed
CN-103864678-A PROCESSES FOR PRODUCING CYCLOALKYLCARBOXIAMIDO-PYRIDINE BENZOIC ACIDS VERTEX PHARMA 2014-06-18 CN disclosed
CN-101910134-B Process for the production of cycloalkylcarboxamido-pyridine benzoic acids VERTEX PHARMA 2014-03-19 CN disclosed
CN-103626744-A Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid VERTEX PHARMA 2014-03-12 CN disclosed
CN-101910156-B Solid forms of 3- (6- (1- (2, 2-difluorobenzo [ D ] [1,3] dioxol-5-yl) cyclopropanecarboxamido) -3-methylpyridin-2-yl) benzoic acid VERTEX PHARMA 2013-12-04 CN disclosed
CN-101910134-A Process for the production of cycloalkylcarboxamido-pyridine benzoic acids VERTEX PHARMA 2010-12-08 CN disclosed
CN-101910156-A Solid forms of 3- (6- (1- (2, 2-difluorobenzo [ D ] [1,3] dioxol-5-yl) cyclopropanecarboxamido) -3-methylpyridin-2-yl) benzoic acid VERTEX PHARMA 2010-12-08 CN disclosed